Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial
Renaud Felten, Valérie Devauchelle‐Pensec, Raphaèle Séror, P. Duffau, David Saadoun, É. Hachulla, Hatron Pierre Yves, Carine Salliot, Aleth Perdriger, Jacques Morel, A. Mékinian, Olivier Vittecoq, Jean‐Marie Berthelot, E. Dernis, Véronique Le Guern, Philippe Dieudé, C. Larroche, Christophe Richez, Thierry Martin, Charles Zarnitsky, Gilles Blaison, P. Kieffer, F. Maurier, Azeddine Dellal, S. Rist, Emmanuel Andrès, A. Contis, Emmanuel Chatelus, Christelle Sordet, Jean Sibilia, Cécile Arnold, Mira Y. Tawk, Ouafaa Aberkane, Lise Holterbach, P. Cacoub, Alain Saraux, Xavier Mariette, Nicolás Meyer, Jacques‐Eric Gottenberg
Topics & Concepts
MedicineTocilizumabClinical endpointPlaceboInternal medicinePopulationPlacebo-controlled studyRheumatologyRandomized controlled trialSurgeryRheumatoid arthritisDouble blindPathologyEnvironmental healthAlternative medicineSalivary Gland Disorders and FunctionsSystemic Lupus Erythematosus ResearchDiabetes and associated disorders